National HIV prevention programs are accelerating progress towards reaching epidemic response goals thanks to multiple new biomedical HIV prevention products that are on the horizon. These products include new pre-exposure prophylaxis methods, such as long-acting injectable cabotegravir. With support from the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Agency for International
With leadership from Ministry of Health expert trainers, RISE supports the introduction of long-acting injectable pre-exposure prophylaxis
